한글목차

자가면역질환 치료제 시장은 2023-2028년 332억 1,880만 달러로 예측기간 동안 6.78%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 자가면역질환 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 강력한 R&D 파이프라인, 생물학적 제제의 표적 치료 메커니즘, 합리적인 가격의 바이오시밀러 채택에 의해 주도되고 있습니다.

이 보고서는 자가면역질환 치료제의 비용 절감이 향후 몇 년 동안 자가면역질환 치료제 시장 성장을 주도할 주요 요인 중 하나라고 분석했습니다. 또한 TNFα 억제제의 시장 지배와 신약의 시장 개척 및 승인은 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023년
• 시장 전망 2023-2028년

제4장 시장 규모 실적

• 자가면역질환 치료제 세계 시장 2018-2022년
• 치료 분야별 부문 분석 2018-2022년
• 유통 채널별 부문 분석 2018-2022년
• 지역별 부문 분석 2018-2022년
• 국가별 부문 분석 2018-2022년

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 치료 분야별

• 시장 세분화
• 비교 : 치료 분야별
• 류마티스 관절염 : 시장 규모와 예측 2023-2028년
• 다발성 경화증 : 시장 규모와 예측 2023-2028년
• 건선 : 시장 규모와 예측 2023-2028년
• 염증성 장질환 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 치료 분야별

제7장 시장 세분화 : 유통 채널별

• 시장 세분화
• 비교 : 유통 채널별
• 병원 : 시장 규모와 예측 2023-2028년
• 약국 : 시장 규모와 예측 2023-2028년
• 드럭스토어/소매 약국 : 시장 규모와 예측 2023-2028년
• 온라인 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 유통 채널별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측 2023-2028년
• 유럽 : 시장 규모와 예측 2023-2028년
• 아시아 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 미국 : 시장 규모와 예측 2023-2028년
• 독일 : 시장 규모와 예측 2023-2028년
• 캐나다 : 시장 규모와 예측 2023-2028년
• 중국 : 시장 규모와 예측 2023-2028년
• 영국 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제11장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca Plc
• Bristol Myers Squibb Co.
• Cardinal Health Inc.
• Delphis Pharmaceutical India
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Hikma Pharmaceuticals Plc
• Johnson and Johnson Services Inc.
• Parvus Therapeutics Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

제13장 부록

영문목차

The autoimmune drugs market is forecasted to grow by USD 33218.8 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, targeted therapeutic mechanism of biologics, and introduction of affordable biosimilars.

Technavio's autoimmune drugs market is segmented as below:

By Therapy Area

• Rheumatoid arthritis
• Multiple sclerosis
• Psoriasis
• Inflammatory bowel disease
• Others

By Distribution Channel

• Hospital
• Pharmacy
• Drug store/Retail pharmacy
• Online

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the reduction in cost of autoimmune drugs as one of the prime reasons driving the autoimmune drugs market growth during the next few years. Also, market dominance by TNF-alpha inhibitors and development and approval of new drugs will lead to sizable demand in the market.

The report on the autoimmune drugs market covers the following areas:

• Autoimmune drugs market sizing
• Autoimmune drugs market forecast
• Autoimmune drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune drugs market vendors that include AbbVie Inc., AdvaCare Pharma, Amgen Inc., AstraZeneca PLC, Bristol Myers Squibb Co., Cardinal Health Inc., Delphis Pharmaceutical India, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Medexus Pharmaceuticals Inc., Parvus Therapeutics Inc., Prometheus Laboratories, Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Wellona Pharma. Also, the autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Therapy Area
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Autoimmune Drugs Market 2018 - 2022
  • Historic Market Size - Data Table on Global Autoimmune Drugs Market 2018 - 2022 ($ million)
• 4.2 Therapy Area segment analysis 2018 - 2022
  • Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy Area

• 6.1 Market segments
  • Chart on Therapy Area - Market share 2023-2028 (%)
  • Data Table on Therapy Area - Market share 2023-2028 (%)
• 6.2 Comparison by Therapy Area
  • Chart on Comparison by Therapy Area
  • Data Table on Comparison by Therapy Area
• 6.3 Rheumatoid arthritis - Market size and forecast 2023-2028
  • Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
  • Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
  • Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
• 6.4 Multiple sclerosis - Market size and forecast 2023-2028
  • Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
  • Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
  • Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
• 6.5 Psoriasis - Market size and forecast 2023-2028
  • Chart on Psoriasis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Psoriasis - Market size and forecast 2023-2028 ($ million)
  • Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
  • Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
• 6.6 Inflammatory bowel disease - Market size and forecast 2023-2028
  • Chart on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
  • Data Table on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
  • Chart on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
  • Data Table on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Therapy Area
  • Market opportunity by Therapy Area ($ million)
  • Data Table on Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 7.3 Hospital - Market size and forecast 2023-2028
  • Chart on Hospital - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospital - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospital - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospital - Year-over-year growth 2023-2028 (%)
• 7.4 Pharmacy - Market size and forecast 2023-2028
  • Chart on Pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
• 7.5 Drug store/retail pharmacy - Market size and forecast 2023-2028
  • Chart on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
• 7.6 Online - Market size and forecast 2023-2028
  • Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Chart on Online - Year-over-year growth 2023-2028 (%)
  • Data Table on Online - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
• 12.4 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
• 12.5 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
• 12.6 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
• 12.7 Cardinal Health Inc.
  • Cardinal Health Inc. - Overview
  • Cardinal Health Inc. - Business segments
  • Cardinal Health Inc. - Key news
  • Cardinal Health Inc. - Key offerings
  • Cardinal Health Inc. - Segment focus
• 12.8 Delphis Pharmaceutical India
  • Delphis Pharmaceutical India - Overview
  • Delphis Pharmaceutical India - Product / Service
  • Delphis Pharmaceutical India - Key offerings
• 12.9 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key news
  • Eli Lilly and Co. - Key offerings
• 12.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.12 Hikma Pharmaceuticals Plc
  • Hikma Pharmaceuticals Plc - Overview
  • Hikma Pharmaceuticals Plc - Business segments
  • Hikma Pharmaceuticals Plc - Key news
  • Hikma Pharmaceuticals Plc - Key offerings
  • Hikma Pharmaceuticals Plc - Segment focus
• 12.13 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.14 Parvus Therapeutics Inc.
  • Parvus Therapeutics Inc. - Overview
  • Parvus Therapeutics Inc. - Product / Service
  • Parvus Therapeutics Inc. - Key offerings
• 12.15 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 12.16 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.17 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
  • 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations